Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hackett

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Research|September 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung TumorigenesisAria Vaishnavi, Joseph Juan, Maebh Jacob, et al.
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Research|September 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung TumorigenesisAria Vaishnavi, Joseph Juan, Maebh Jacob, et al.
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Pageof 3